Provided by Tiger Fintech (Singapore) Pte. Ltd.

Elevation Oncology, Inc.

0.3720
-0.0061-1.61%
Post-market: 0.37200.00000.00%16:30 EDT
Volume:1.24M
Turnover:472.96K
Market Cap:22.03M
PE:-0.48
High:0.3959
Open:0.3825
Low:0.3600
Close:0.3781
Loading ...

Elevation Oncology Price Target Maintained With a $5.00/Share by Stephens & Co.

Dow Jones
·
07 Mar

Promising Outlook and Strong Financials Justify Buy Rating for Elevation Oncology

TIPRANKS
·
07 Mar

Elevation Oncology Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
07 Mar

Elevation Oncology Q4 2024 GAAP EPS $(0.18) Beats $(0.22) Estimate

Benzinga
·
07 Mar

Elevation Oncology reports Q4 EPS (18c), consensus (22c)

TIPRANKS
·
07 Mar

Elevation Oncology sees current cash and equivalents sufficient into 2026

TIPRANKS
·
07 Mar

Elevation Oncology Q4 Basic EPS USD -0.18

THOMSON REUTERS
·
07 Mar

Press Release: Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Achievements

Dow Jones
·
07 Mar

Elevation Oncology Inc expected to post a loss of 22 cents a share - Earnings Preview

Reuters
·
28 Feb

Elevation Oncology to Participate in Upcoming Investor Conferences

PR Newswire
·
25 Feb

Elevation Oncology Announces CSO Resignation

TIPRANKS
·
01 Feb

Elevation Oncology Price Target Maintained With a $6.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Jan

Elevation Oncology’s Promising Clinical Progress and Strategic Evaluations Support Buy Rating

TIPRANKS
·
14 Jan

BRIEF-Elevation Oncology Provides Updates On Differentiated Adc Programs And Upcoming Milestones

Reuters
·
13 Jan

Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming Milestones

THOMSON REUTERS
·
13 Jan

Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming Milestones

PR Newswire
·
13 Jan

Elevation Oncology Initiated at Outperform by William Blair

Dow Jones
·
03 Jan

William Blair Initiates Elevation Oncology at Outperform

MT Newswires Live
·
03 Jan

Elevation Oncology initiated with an Outperform at William Blair

TIPRANKS
·
03 Jan

Elevation Oncology Price Target Maintained With a $7.00/Share by JMP Securities

Dow Jones
·
19 Dec 2024